###begin article-title 0
Neurotrophin-3 and FLT3 Tyrosine Kinase Receptor in Perinatal Life
###end article-title 0
###begin p 1
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 638 639 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 48 55 <span type="species:ncbi:9606">infants</span>
Our aim is to determine-in 30 healthy full-term infants and their mothers-circulating levels of neurotrophin-3 (NT-3) (important for antenatal and postnatal brain development and implicated in the immune response) and FLT3 tyrosine kinase receptor (FLT3) (controlling hematopoiesis and found in the nervous tissue), in the fetal and neonatal life. NT-3 levels, in contrast to FLT3 ones, increased significantly on the fourth postnatal day in relation to the low levels found in the mother, fetus, and day 1 neonate (P = .03, respectively). Maternal and umbilical NT3 levels positively correlated with respective FLT3 levels (P = .003 and P = .03). Circulating NT-3 levels increased in early neonatal life, possibly due to exposure to various stimuli soon after birth. FLT3 levels do not seem to behave accordingly, although these two substances probably synergize.
###end p 1
###begin title 2
INTRODUCTION
###end title 2
###begin p 3
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 275 276 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 478 479 478 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 484 485 484 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 724 725 724 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 861 862 861 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
Neurotrophin-3 (NT-3) belongs to the neurotrophin family, which includes, among others, the nerve growth factor and the brain-derived neurotrophic factor (BDNF) [1]. Neurotrophins exert antiapoptotic activities in neurons [2] and are implicated in higher neuronal functions [3] and neurotransmitter expression [4]. Therefore, neurotrophins may play important roles in antenatal and postnatal brain development. In addition, neurotrophins are involved in the immune response [5, 6, 7, 8]. Moreover, nerve growth factor, BDNF, and NT-3 act on tyrosine kinase A, B, and C receptors, respectively. It has recently been reported that in neonatal age circulating neurotrophin levels could reflect the degree of neuronal maturity [1], since, at this age, due to the immature blood-brain barrier, neurotrophin blood levels may also represent concentrations in the CNS [9].
###end p 3
###begin p 4
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 243 245 243 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 597 599 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 826 828 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 921 923 921 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
The FLT3 receptor (FLT3) is a member of the class III receptor tyrosine kinases [10]. Related members of this family of receptors together with their respective ligands have been shown to control numerous distinct stages of hematopoiesis [11, 12]. Recently, regions of the brain have been shown to harbor neural stem/progenitor cells that retain the capacity to proliferate and to give rise to new cells throughout the lifetime of an animal [10, 13]. Thus, they generate neurons, oligodendrocytes, astrocytes, but also retain the ability to repopulate hematopoietic systems of irradiated animals [14] and to give rise to multiple tissue types when grown in the presence of embryonic stem cells [15]. On the other hand, hematopoietic stem cells have been shown to give rise to neurons, when transplanted into mice [16, 17, 18, 19]. In this respect, many studies have confirmed the presence of FLT3 mRNA in nervous tissue [20, 21].
###end p 4
###begin p 5
This study was based on the hypothesis that a possible interaction between hematopoietic and neuronal activity in the central nervous system, possibly also representing the state of maturity, might be reflected in the periphery. Thus, we aimed to determine circulating levels of NT-3 and FLT3 in full-term neonates and correlate these levels with gestational age, gender, and mode of delivery.
###end p 5
###begin title 6
MATERIALS AND METHODS
###end title 6
###begin p 7
###xml 727 734 723 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 576 583 <span type="species:ncbi:9606">infants</span>
###xml 662 669 <span type="species:ncbi:9606">infants</span>
The study was approved by the Ethics Committee of our teaching hospital and informed consent was obtained from participating mothers. The study included 30 healthy, infection-free, nonsmoking parturients (mean age: 25.6 +/- 3.4, range: 20-40 years) and their healthy neonates appropriate for gestational age and born after single uncomplicated pregnancy and delivery. Apgar scores were >/= 8 in the first and fifth minutes. Placentas were in all cases normal in appearance and weight. Complete blood count and C-reactive protein were within normal ranges in all newborns. All infants received breast milk. Developed jaundice required phototherapy treatment in 5 infants. Demographic data of participating neonates are shown in Table 1.
###end p 7
###begin p 8
###xml 505 512 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#176;</sup>
The study assessed circulating levels of NT-3 and FLT3. Thus, blood was taken from (a) the mothers (MS) before delivery (at the first stage of labor, or before receiving anesthesia in cases of elective cesarean section), (b) the doubly clamped umbilical cord (UC) at delivery (UC representing fetal state), and the neonates (c) on the first (N1) and (d) fourth days (N4). The blood was collected in pyrogen-free tubes; following centrifugation the supernatant serum and EDTA plasma were kept frozen at -80degrees C until assay. NT-3 and FLT3 were determined in serum and EDTA-plasma, respectively, by enzyme immunoassays (R&D Systems Minneapolis, Minn 55413, catalogue numbers DY 267 and DFK 00, respectively). The minimum detectable concentration, intraassay and interassay coefficients of variations were for NT-3 1 pg/mL, 8.7% and 14.9%, and for FLT3 less than 7 pg/mL, 2.7% and 11.1%, respectively.
###end p 8
###begin title 9
STATISTICAL ANALYSIS
###end title 9
###begin p 10
###xml 183 184 183 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Variables were checked for normality of their distribution by Kolmogorov-Smirnov one-sample test. Data not normally distributed were log 10 transformed (NT-3 MS). Unpaired and paired t test was used in the analysis. Furthermore, Pearson correlation coefficient was calculated.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin p 12
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 435 436 435 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 449 450 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The circulating NT-3 and FLT3 levels in MS, UC, N1, and N4 are presented in Table 2. Statistically significant differences were found in NT-3 levels between MS and N4 (P = .03), UC and N4 (P = .03), and N1 and N4 (P = .03). On the other hand, FLT3 circulating concentrations did not present any difference between the various samples. In addition, MS NT-3, as well as UC NT-3 levels, positively correlated with respective FLT3 levels (P = .003, and P = .03). No correlation with gender, gestational age, or mode of delivery was found for either NT-3 or FLT3.
###end p 12
###begin title 13
DISCUSSION
###end title 13
###begin p 14
The results of this study indicate that NT-3 serum concentrations rise significantly on the forth day of life, from the low levels encountered in the umbilical cord and on the first postnatal day. Nevertheless, such rise could not be found concerning FLT3.
###end p 14
###begin p 15
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 636 638 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 759 761 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 853 854 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 966 968 966 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 990 992 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1312 1314 1312 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1407 1411 1407 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;</italic>
###xml 1454 1459 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#945;</italic>
###xml 875 881 <span type="species:ncbi:9606">infant</span>
The significant increase of NT-3 on the fourth postnatal day may indicate its secretion from the nervous and immune systems of the neonate, as a result of exposure to various stimuli soon after birth. Respectively, in a recent study we demonstrated that the BDNF circulating levels increased significantly in the postnatal period, as compared to the fetal levels [22]. It has been stated that neurotrophins are important for the physiological function of the peripheral as well as the central nervous system, contributing to developmental maturity of the cortex and plasticity of the synapses, leading to the refinement of connections [23]. In addition, previous studies reported that neurotrophins are produced, stored, and released by various immune cells [24], and elevated plasma levels are found in inflammatory, autoimmune, and allergic diseases [8]. Transition of the infant to extrauterine life, where he or she is exposed to a variety of antigenic stimuli [25], including feeding [26], might be responsible for the postnatal significant increase of NT-3. Furthermore, it has been reported that the elevation of neurotrophins might also be a consequence of proinflammatory cytokines [27], the production of which then again is influenced by the former [28]. Accordingly, we have previously demonstrated [29] a significant increase in circulating levels of the proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in healthy neonates soon after birth.
###end p 15
###begin p 16
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
Lastly, one should consider a third parameter possibly implicated in the increased postnatal circulating NT-3 levels: its secretion by vascular endothelial cells [30]. The latter multiply and migrate, contributing to the formation of new blood vessels from preexisting ones (angiogenesis) [31], when rapid growth and development is taking place [32], particularly in the third trimester of pregnancy [33], and to a lesser extent in neonatal life.
###end p 16
###begin p 17
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
It has been previously described that many cytokines are shared by the haematopoietic and nervous systems and they exert different functions in different contexts [10]. Nerve growth factor can act as a colony-stimulating factor, as it stimulates immature erythroleukemic cell lines and bone-marrow-derived precursor cells to proliferate [34]. FLT3 is most robustly expressed on differentiated postmitotic neurons, whereas in the hematopoietic system, immature cells preferentially express FLT3 [10]. The lack of increased FLT3 levels in fetal and neonatal samples, according to this study, could possibly be attributed to the fact that examined peripheral blood did not contain immature hematopoietic cells, as neonates were full term and infection free. On the other hand, it has been shown that FLT3 does not play a role as a trophic factor during the early stages of development within the central nervous system [35].
###end p 17
###begin p 18
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
Our finding that MS and UC NT-3 levels, positively correlated with MS and UC FLT3 levels, respectively, could be explained in parallel with the ability of FLT3 to synergize with NGF, thus to enhance the competence of neurons to respond to neurotrophins [10]. However, a further explanation could take into account the interactions of the nervous and immune systems, particularly under stress situations, as it happens in labor and delivery.
###end p 18
###begin p 19
In conclusion, circulating NT-3 levels increase during the early neonatal life. However, circulating FLT3 levels do not seem to behave accordingly, although these two substances probably synergize.
###end p 19
###begin article-title 20
###xml 60 67 <span type="species:ncbi:9606">infants</span>
Changes in neurotrophin levels in umbilical cord blood from infants with different gestational ages and clinical conditions
###end article-title 20
###begin article-title 21
Signaling pathways mediating anti-apoptotic action of neurotrophins
###end article-title 21
###begin article-title 22
Trophic factors: An evolutionary cul-de-sac or door into higher neuronal function?
###end article-title 22
###begin article-title 23
Roles of neurotrophins on synaptic development and functions in the central nervous system
###end article-title 23
###begin article-title 24
Nerve growth factor production by lymphocytes
###end article-title 24
###begin article-title 25
IgE receptor-mediated release of nerve growth factor by mast cells
###end article-title 25
###begin article-title 26
Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation
###end article-title 26
###begin article-title 27
The influence of inhalative corticosteroids on circulating nerve growth factor, brain-derived neurotrophic factor and neurotrophin-3 in allergic asthmatics
###end article-title 27
###begin article-title 28
The FLT3 tyrosine kinase receptor inhibits neural stem/progenitor cell proliferation and collaborates with NGF to promote neuronal survival
###end article-title 28
###begin article-title 29
c-kit ligand and Flt3 ligand: factors with overlapping yet distinct activities
###end article-title 29
###begin article-title 30
Characterization of the gene-product of the Steel locus
###end article-title 30
###begin article-title 31
Marrow-mindedness: a perspective on neuropoiesis
###end article-title 31
###begin article-title 32
Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo
###end article-title 32
###begin article-title 33
Generalized potential of adult neural stem cells
###end article-title 33
###begin article-title 34
###xml 65 69 <span type="species:ncbi:10090">mice</span>
From marrow to brain: expression of neuronal phenotypes in adult mice
###end article-title 34
###begin article-title 35
Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow
###end article-title 35
###begin article-title 36
###xml 6 9 <span type="species:ncbi:10116">rat</span>
###xml 14 19 <span type="species:ncbi:9606">human</span>
Adult rat and human bone marrow stromal cells differentiate into neurons
###end article-title 36
###begin article-title 37
Adult bone marrow stromal cells differentiate into neural cells in vitro
###end article-title 37
###begin article-title 38
###xml 45 50 <span type="species:ncbi:10090">mouse</span>
Developmental expression of flt3 mRNA in the mouse brain
###end article-title 38
###begin article-title 39
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Expression of Flt3 tyrosine kinase receptor gene in mouse hematopoietic and nervous tissues
###end article-title 39
###begin article-title 40
Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates
###end article-title 40
###begin article-title 41
Role of neurotrophins in synapse development and plasticity
###end article-title 41
###begin article-title 42
Mast cells synthesize, store, and release nerve growth factor
###end article-title 42
###begin article-title 43
Immunology of the fetus and newborn
###end article-title 43
###begin article-title 44
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 69 72 <span type="species:ncbi:9913">cow</span>
Response of bifidobacterium species to growth promoters in human and cow milk
###end article-title 44
###begin article-title 45
###xml 63 78 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of tumour necrosis factor alpha in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyltransferase activity
###end article-title 45
###begin article-title 46
Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism
###end article-title 46
###begin article-title 47
Patterns of inflammatory cytokine serum concentrations during the perinatal period
###end article-title 47
###begin article-title 48
Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor
###end article-title 48
###begin article-title 49
Angiogenic factors
###end article-title 49
###begin article-title 50
The codependence of angiogenesis and chronic inflammation
###end article-title 50
###begin article-title 51
Vascular development: cellular and molecular regulation
###end article-title 51
###begin article-title 52
Expression and functionality of the trkA proto-oncogene product/NGF receptor in undifferentiated hematopoietic cells
###end article-title 52
###begin article-title 53
Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors
###end article-title 53
###begin p 54
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Demographic data of participating full-term (n = 30) neonates.
###end p 54
###begin p 55
###xml 216 217 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Circulating neurotrophin-3 (NT-3) and FLT3 tyrosine kinase receptor (FLT3) (mean +/-SD) levels (pg/mL) in mothers (MS), umbilical cords (UC) and neonates on the first (N1) and fourth (N4) days of full-term neonates (n = 30).
###end p 55

